ライフサイエンスコーパス: postmarketing surveillance

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 se complications will likely require careful postmarketing surveillance.

2 reported to Merck, the manufacturer, through postmarketing surveillance.

3 Proactive postmarketing surveillance and further studies are pivot

4 lestra (sucrose polyester) called for active postmarketing surveillance because preapproval studies s

5 The ASRS TSC encourages active postmarketing surveillance by all physicians.

6 data submitted to Merck from routine global postmarketing surveillance, combined with information fr

7 r examining the available literature and the postmarketing surveillance data, proposed a clinically b

8 in prescribing this drug pending additional postmarketing surveillance data.

9 Examination of the FDA postmarketing surveillance databases revealed a low repo

10 Longer-term clinical trials and careful postmarketing surveillance during the next several decad

11 Careful postmarketing surveillance for adverse effects, especial

12 f monitoring both pharmaceutical quality and postmarketing surveillance for adverse events.

13 recent studies have examined how frequently postmarketing surveillance identifies important ADRs.

14 Postmarketing surveillance indicates that the diversion

15 However, longer-term trial results and postmarketing surveillance of major adverse events will

16 ition, observational studies can be used for postmarketing surveillance of new cancer treatments, par

17 ing and documenting adverse effects; and (8) postmarketing surveillance of therapy outcomes.

18 Additional postmarketing surveillance of these and other serious ad

19 (VAERS) is the passive reporting system for postmarketing surveillance of vaccine safety in the Unit

20 ministration mandated that companies conduct postmarketing surveillance (PMS) studies of approved ste

21 Postmarketing surveillance revealed a potential serious

22 and the importance of internationally robust postmarketing surveillance strategies as crucial compone

23 n the near future, with a call for effective postmarketing surveillance studies for all of the new en

24 This active postmarketing surveillance study of a food additive sugg

25 that the agency's drug review procedures and postmarketing surveillance system after a drug has been

26 This study demonstrates the power of active postmarketing surveillance to identify or exclude events

27 authorisation procedures mandated increased postmarketing surveillance to monitor vaccine safety.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。